Literature DB >> 2240161

Development of multiple necrotizing enteritis induced by a tumor necrosis factor-like cytokine from lipopolysaccharide-stimulated peritoneal macrophages in rats.

K Torimoto1, N Sato, M Okubo, A Yagihashi, Y Wada, I Hara, H Hayasaka, K Kikuchi.   

Abstract

We report the development of an animal model of multiple necrotizing enteritis (MNE) in rats. When rats were injected directly with a culture supernatant of lipopolysaccharide (LPS)-stimulated rat peritoneal macrophages into the abdominal aorta, the overt pathologic lesions of MNE developed within 30 minutes after injection. The rats showed an elevated level of blood fibrinogen degradation product content even 30 minutes after injection. Furthermore the rats that were pretreated intravenously with heparin sulfate did not develop MNE, indicating the acute disturbances of blood microcirculation in the intestine. Multiple necrotizing enteritis was developed also by the injection with recombinant tumor necrosis factor (rTNF) but rarely was observed with even a high dose of recombinant interleukin-1 (rIL-1) or platelet-activating factor (PAF). The supernatant was cytotoxic in vitro to TNF-susceptible LM and many other cells but was less cytotoxic to the TNF-resistant LR line. Partial purification of the supernatant suggested that the supernatant contained a cytokine that has biochemical features of TNF. Furthermore polyclonal anti-TNF antibody could inhibit not only the cytotoxicity in vitro but also MNE development in vivo by this factor. These data strongly indicate that MNE possibly could be caused by a TNF-like cytokine produced by macrophages that are stimulated by the endotoxin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2240161      PMCID: PMC1877684     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  27 in total

1.  Platelet-activating factor-induced ischemic bowel necrosis. An investigation of secondary mediators in its pathogenesis.

Authors:  W Hsueh; F Gonzalez-Crussi; J L Arroyave
Journal:  Am J Pathol       Date:  1986-02       Impact factor: 4.307

2.  Proposal of standardized methods and reference for assaying recombinant human tumor necrosis factor.

Authors:  S Yamazaki; E Onishi; K Enami; K Natori; M Kohase; H Sakamoto; M Tanouchi; H Hayashi
Journal:  Jpn J Med Sci Biol       Date:  1986-06

3.  Establishment of murine endothelial cell lines that develop angiosarcomas in vivo: brief demonstration of a proposed animal model for Kaposi's sarcoma.

Authors:  N Sato; T Sato; S Takahashi; K Kikuchi
Journal:  Cancer Res       Date:  1986-01       Impact factor: 12.701

4.  Comparison of in vitro cell cytotoxic assays for tumor necrosis factor.

Authors:  D A Flick; G E Gifford
Journal:  J Immunol Methods       Date:  1984-03-30       Impact factor: 2.303

5.  Shock and tissue injury induced by recombinant human cachectin.

Authors:  K J Tracey; B Beutler; S F Lowry; J Merryweather; S Wolpe; I W Milsark; R J Hariri; T J Fahey; A Zentella; J D Albert
Journal:  Science       Date:  1986-10-24       Impact factor: 47.728

6.  Characterization of tumor rejection antigen molecules of chemically induced murine colon tumor C-C26.

Authors:  N Sato; A Yagihashi; M Okubo; T Torigoe; S Takahashi; T Sato; K Kikuchi
Journal:  Cancer Res       Date:  1987-06-15       Impact factor: 12.701

7.  Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1.

Authors:  M P Bevilacqua; J S Pober; G R Majeau; W Fiers; R S Cotran; M A Gimbrone
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

8.  Purification and partial amino acid sequence of rabbit tumor necrosis factor.

Authors:  K Haranaka; N Satomi; A Sakurai; H Nariuchi
Journal:  Int J Cancer       Date:  1985-09-15       Impact factor: 7.396

9.  Self-regulation of procoagulant events on the endothelial cell surface.

Authors:  D M Stern; I Bank; P P Nawroth; J Cassimeris; W Kisiel; J W Fenton; C Dinarello; L Chess; E A Jaffe
Journal:  J Exp Med       Date:  1985-10-01       Impact factor: 14.307

10.  Modulation of endothelial cell hemostatic properties by tumor necrosis factor.

Authors:  P P Nawroth; D M Stern
Journal:  J Exp Med       Date:  1986-03-01       Impact factor: 14.307

View more
  6 in total

1.  Secretion imbalance between tumour necrosis factor and its inhibitor in inflammatory bowel disease.

Authors:  M Noguchi; N Hiwatashi; Z Liu; T Toyota
Journal:  Gut       Date:  1998-08       Impact factor: 23.059

2.  Pathogenesis of neonatal necrotizing enterocolitis: a study of the role of intraluminal pressure, age and bacterial concentration.

Authors:  K L Chan; S P Ng; K W Chan; Y H Wo; P K H Tam
Journal:  Pediatr Surg Int       Date:  2003-10-09       Impact factor: 1.827

Review 3.  Necrotizing enterocolitis: a multifactorial disease with no cure.

Authors:  Kareena-L Schnabl; John-E Van Aerde; Alan-Br Thomson; Michael-T Clandinin
Journal:  World J Gastroenterol       Date:  2008-04-14       Impact factor: 5.742

4.  Tumor necrosis factor-{alpha} downregulates intestinal NHE8 expression by reducing basal promoter activity.

Authors:  Hua Xu; Huacong Chen; Jiali Dong; Jing Li; Rongji Chen; Jennifer K Uno; Fayez K Ghishan
Journal:  Am J Physiol Cell Physiol       Date:  2008-12-24       Impact factor: 4.249

5.  Cytokine response by human monocytes to Clostridium difficile toxin A and toxin B.

Authors:  W A Flegel; F Müller; W Däubener; H G Fischer; U Hadding; H Northoff
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

Review 6.  The enterotoxicity of Clostridium difficile toxins.

Authors:  Xingmin Sun; Tor Savidge; Hanping Feng
Journal:  Toxins (Basel)       Date:  2010-07-14       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.